These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 28791306)
21. Comparison of migration disturbance potency of epigallocatechin gallate (EGCG) synthetic analogs and EGCG PEGylated PLGA nanoparticles in rat neurospheres. Kühne BA; Puig T; Ruiz-Martínez S; Crous-Masó J; Planas M; Feliu L; Cano A; García ML; Fritsche E; Llobet JM; Gómez-Catalán J; Barenys M Food Chem Toxicol; 2019 Jan; 123():195-204. PubMed ID: 30367911 [TBL] [Abstract][Full Text] [Related]
22. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention. Rocha S; Generalov R; Pereira Mdo C; Peres I; Juzenas P; Coelho MA Nanomedicine (Lond); 2011 Jan; 6(1):79-87. PubMed ID: 21182420 [TBL] [Abstract][Full Text] [Related]
23. Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy. Cano A; Ettcheto M; Espina M; Auladell C; Calpena AC; Folch J; Barenys M; Sánchez-López E; Camins A; García ML Nanomedicine; 2018 Jun; 14(4):1073-1085. PubMed ID: 29454994 [TBL] [Abstract][Full Text] [Related]
24. The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles. Hsieh DS; Wang H; Tan SW; Huang YH; Tsai CY; Yeh MK; Wu CJ Biomaterials; 2011 Oct; 32(30):7633-40. PubMed ID: 21782236 [TBL] [Abstract][Full Text] [Related]
25. Fabrication of epigallocatechin-3-gallate nanocarrier based on glycosylated casein: stability and interaction mechanism. Xue J; Tan C; Zhang X; Feng B; Xia S J Agric Food Chem; 2014 May; 62(20):4677-84. PubMed ID: 24670204 [TBL] [Abstract][Full Text] [Related]
26. pH-Sensitive Nanoparticles of Epigallocatechin-3-Gallate in Enhanced Colorectal Cancer Therapy. Bhattacharya S; Sangave PC; Belemkar S; Anjum MM Nanomedicine (Lond); 2024 Mar; 19(6):459-481. PubMed ID: 38223987 [TBL] [Abstract][Full Text] [Related]
27. Zeolites with Divalent Ions as Carriers in the Delivery of Epigallocatechin Gallate. Sandomierski M; Chojnacka M; Ratajczak M; Voelkel A ACS Biomater Sci Eng; 2023 Sep; 9(9):5322-5331. PubMed ID: 37540564 [TBL] [Abstract][Full Text] [Related]
28. Niosomes Consisting of Tween-60 and Cholesterol Improve the Chemical Stability and Antioxidant Activity of (-)-Epigallocatechin Gallate under Intestinal Tract Conditions. Liang R; Chen L; Yokoyama W; Williams PA; Zhong F J Agric Food Chem; 2016 Dec; 64(48):9180-9188. PubMed ID: 27933988 [TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory Action of Green Tea. Ohishi T; Goto S; Monira P; Isemura M; Nakamura Y Antiinflamm Antiallergy Agents Med Chem; 2016; 15(2):74-90. PubMed ID: 27634207 [TBL] [Abstract][Full Text] [Related]
30. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy. Williamson MP; McCormick TG; Nance CL; Shearer WT J Allergy Clin Immunol; 2006 Dec; 118(6):1369-74. PubMed ID: 17157668 [TBL] [Abstract][Full Text] [Related]
31. Chitosan-PEG-folate-Fe(III) complexes as nanocarriers of epigallocatechin-3-gallate. Echeverri-Cuartas CE; Agudelo NA; Gartner C Int J Biol Macromol; 2020 Dec; 165(Pt B):2909-2919. PubMed ID: 33736290 [TBL] [Abstract][Full Text] [Related]
32. In vitro electrocardiographic and cardiac ion channel effects of (-)-epigallocatechin-3-gallate, the main catechin of green tea. Kang J; Cheng H; Ji J; Incardona J; Rampe D J Pharmacol Exp Ther; 2010 Aug; 334(2):619-26. PubMed ID: 20484151 [TBL] [Abstract][Full Text] [Related]
33. Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles. Zhang J; Nie S; Martinez-Zaguilan R; Sennoune SR; Wang S J Nutr Biochem; 2016 Apr; 30():14-23. PubMed ID: 27012617 [TBL] [Abstract][Full Text] [Related]
34. Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome. Legeay S; Rodier M; Fillon L; Faure S; Clere N Nutrients; 2015 Jul; 7(7):5443-68. PubMed ID: 26198245 [TBL] [Abstract][Full Text] [Related]
35. Development and Optimization of Epigallocatechin-3-Gallate (EGCG) Nano Phytosome Using Design of Experiment (DoE) and Their In Vivo Anti-Inflammatory Studies. H Shariare M; Afnan K; Iqbal F; A Altamimi M; Ahamad SR; S Aldughaim M; K Alanazi F; Kazi M Molecules; 2020 Nov; 25(22):. PubMed ID: 33233756 [TBL] [Abstract][Full Text] [Related]
36. Native and thermally modified protein-polyphenol coassemblies: lactoferrin-based nanoparticles and submicrometer particles as protective vehicles for (-)-epigallocatechin-3-gallate. Yang W; Xu C; Liu F; Yuan F; Gao Y J Agric Food Chem; 2014 Nov; 62(44):10816-27. PubMed ID: 25310084 [TBL] [Abstract][Full Text] [Related]
37. Food-grade Encapsulation Systems for (-)-Epigallocatechin Gallate. Shi M; Shi YL; Li XM; Yang R; Cai ZY; Li QS; Ma SC; Ye JH; Lu JL; Liang YR; Zheng XQ Molecules; 2018 Feb; 23(2):. PubMed ID: 29462972 [TBL] [Abstract][Full Text] [Related]
38. Fabrication of self-assembled (-)-epigallocatechin gallate (EGCG) ovalbumin-dextran conjugate nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cells. Li Z; Gu L J Agric Food Chem; 2014 Feb; 62(6):1301-9. PubMed ID: 24446922 [TBL] [Abstract][Full Text] [Related]
39. Preservation of (-)-epigallocatechin-3-gallate antioxidant properties loaded in heat treated β-lactoglobulin nanoparticles. Li B; Du W; Jin J; Du Q J Agric Food Chem; 2012 Apr; 60(13):3477-84. PubMed ID: 22409289 [TBL] [Abstract][Full Text] [Related]
40. Encapsulation of (-)-epigallocatechin gallate into liposomes and into alginate or chitosan microparticles reinforced with liposomes. Istenič K; Cerc Korošec R; Poklar Ulrih N J Sci Food Agric; 2016 Oct; 96(13):4623-32. PubMed ID: 26921243 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]